De Waele, Jan J. http://orcid.org/0000-0003-1017-9748
Akova, Murat
Antonelli, Massimo
Canton, Rafael
Carlet, Jean
De Backer, Daniel
Dimopoulos, George
Garnacho-Montero, José
Kesecioglu, Jozef
Lipman, Jeffrey
Mer, Mervyn
Paiva, José-Artur
Poljak, Mario
Roberts, Jason A.
Rodriguez Bano, Jesus
Timsit, Jean-François
Zahar, Jean-Ralph
Bassetti, Matteo
Article History
Received: 11 October 2017
Accepted: 19 December 2017
First Online: 29 December 2017
Compliance with ethical standards
:
: Jan De Waele has consulted for Bayer Healthcare, Merck, and Pfizer. Murat Akova had received grants to support institutional research projects from Pfizer and MSD, and has participated accredited educational activities by Pfizer and Astellas. Massimo Antonelli received research grants from Orion, Toray, Pfizer and MSD, and received fees from GE, Maquet, Nihon Koden, Intersurgical and Orion for participation to International Boards. Rafael Canton has participated in educational programs sponsored by Angelini, AstraZeneca, Pfizer and MSD, and in research activities funded by AstraZeneca and MSD. Jean Carlet has participated in advisory boards with Beckton Dikinson, and has been a consultant for Cooper Alliance. George Dimopoulos has been a consultant for Bayer Healthcare, Merck, and Pfizer and Glenmark. José Garnacho-Montero has served as speaker for MSD, Astellas and has received research support from Astellas. Jozef Kesecioglu has received honorarium from Xenios AG. Jeff Lipman has consulted for Bayer and MSD. Mervyn Mer has participated in educational activities funded by MSD, Pfizer, Gilead, AstraZeneca, Sun Pharma. Jason Roberts has consulted for Astellas, bioMerieux and Bayer and has received investigator-initiated grant funding from MSD, Cardeas Pharma and The Medicines Company. Jesus Rodriguez-Bano has participated in research projects from AstraZeneca and InfectoPharm, and participated in accredited educational activities funded by Merck. Jean-Francois Timsit has participated in scientific boards of Bayer, Merck, Gilead, Paratek, Maat Pharma; the University Hospital of Jean-Francois Timsit received research grants from Merck, 3 M and Astellas and participated in advisory boards for 3 M, Merck, Gilead, Pfizer, Paratek, Bayer,. Jean-Ralph Zahar has consulted for Merck and Pfizer. The other authors state that they have no conflicts of interest. Matteo Bassetti has participated in advisory boards and/or received speaker honoraria from Achaogen, Angelini, Astellas, AstraZeneca, Bayer, Basilea, Gilead, Menarini, MSD, Pfizer, The Medicine Company, Tetraphase and Vifor.
Free to read: This content has been made available to all.